Filing Details

Accession Number:
0000899243-17-022018
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-13 17:50:19
Reporting Period:
2017-09-11
Accepted Time:
2017-09-13 17:50:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1365216 Sucampo Pharmaceuticals Inc. SCMP Pharmaceutical Preparations (2834) 133929237
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1383384 Sachiko Kuno 28307 Mallard Drive
Easton MD 21601
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2017-09-11 1,000,000 $12.00 7,137,344 No 4 S Indirect By SK Impact Fund, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By SK Impact Fund, LLC
Footnotes
  1. On September 11, 2017, the reporting person sold 1,000,000 shares through a block trade pursuant to Rule 144 under the Securities Act of 1933, as amended.